Clinical parameters and outcomes of pneumocystis jiroveci pneumonia in non-HIV/AIDS patients

Chinese Medical Journal

Volumn 119, Issue 3, 2006, Pages 234-237

  Cao, Bin ^a   Wang, Hui ^a   Wang, Peng ^a   Li, Meng Tao ^a   Zhu, Yuan Jue ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Connective tissue disease; Corticosteroid; Human immunodeficiency virus; Pneumocystis jiroveci pneumonia

Indexed keywords

CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; MEROPENEM; PREDNISONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; FEMALE; FIBEROPTIC BRONCHOSCOPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LABORATORY TEST; MALE; NONHUMAN; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; SEROLOGY; SPUTUM ANALYSIS; THORAX RADIOGRAPHY; CHILD; MIDDLE AGED; MORTALITY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMOCYSTIS JIROVECI; PNEUMONIA, PNEUMOCYSTIS; RISK FACTORS;

EID: 33645734901     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200602010-00012     Document Type: Article

References (13)

1. Sepkowita KA. Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin Infect Dis 2002; 34: 1098-1107.
2. Walzer PD, Perl DP, Krogstad DJ, Rawson PG, Schultz MG. Pneumocystis jiroveci pneumonia in the United States: epidemiologic, diagnostic and clinical features. Ann Intern Med 1974; 80: 83-93.
3. Godeau B, Coutant-Perronne V, Le Thi Huong D, Guillevin L, Magadur G, de Bandt M, et al. Pneumocystis jiroveci pneumonia in the course of connective tissue disease: report of 34 cases. J Rheumotol 1994; 21: 246-251.
4. Cano S, Capote F, Pereira A, Calderon E, Castillo J. Pneumocystis jiroveci pneumonia in patients without predisposing illnesses: acute episode and follow-up of five cases. Chest 1993; 104: 376-381.
5. Jacobs JL, Libby DM, Winters RA, Gelmont DM, Fried ED, Hartman BJ, et al. A cluster of Pneumocystis jiroveci pneumonia in adults without predisposing illnesses. N Engl J Med 1991; 324: 246-250.
6. Godwin CR, Brown DT, Gill VJ, Massur H, Ognibene FP. Sputum induction: a quick and sensitive technique for diagnosing Pneumocyxtis carinii pneumonia in immunosuppressive patients. Respir Care 1991; 36: 33-39.
7. Kelleher P, Misbah SA. What is Good's syndrome? Immunological abnormalities in patients with thymoma. J Clin Pathol 2003; 56: 12-16.
8. Ognibene FP, Shelhamer JH, Hoffman GS, Kerr GS, Reda D, Fauci AS, et al. Pneumocystis jiroveci pneumonia: A major complication on immunosuppressive therapy in patients with Wegener's granulomatosis. Am J Respir Crit Care Med 1995; 151: 795-799.
9. Medrano FJ, Montes-Cano M, Conde M, de la Horre C, Respaldiza N, Gasch A, et al. Pneumocyctis jirovecii in general population. Emerg Infect Dis 2005; 11: 245-250.
10. Smith R, Levine S, Lewis M. Prognosis of patients with AIDS requiring intensive care. Chest 1989; 96: 857-861
11. Chu D. Predicting survival in AIDS patients with respiratory failure: application of APACHE II scoring system. Crit Care Clin 1993; 9: 89-105.
12. Smith RL, Ripps CS, Lewis ML. Elevated lactate dehydrogenase values in patients with Pneumocystis jiroveci pneumonia. Chest 1988; 93: 987-992.
13. Garay SM, Greene J. Prognostic indicators in the initial presentation of Pneumocystis jiroveci pneumonia. Chest 1989; 95: 769-772.